627526-90-3 Usage
General Description
1-Bromo-3-difluoromethyl-5-fluorobenzene is a chemical compound with the molecular formula C7H4BrF3. It is a colorless liquid with a strong, pungent odor that is used in the production of pharmaceuticals, agrochemicals, and other organic compounds. It is a halogenated aromatic compound containing a bromine atom and two fluorine atoms, which gives it high reactivity and potential for use in various chemical reactions. The compound is a versatile building block in organic synthesis, and its unique structure and properties make it valuable in the development of new materials and pharmaceuticals. However, it is important to handle this chemical with caution, as it can be hazardous to human health and the environment if not properly managed and disposed of.
Check Digit Verification of cas no
The CAS Registry Mumber 627526-90-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,7,5,2 and 6 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 627526-90:
(8*6)+(7*2)+(6*7)+(5*5)+(4*2)+(3*6)+(2*9)+(1*0)=173
173 % 10 = 3
So 627526-90-3 is a valid CAS Registry Number.
InChI:InChI=1S/C7H4BrF3/c8-5-1-4(7(10)11)2-6(9)3-5/h1-3,7H
627526-90-3Relevant articles and documents
HETEROARYL SUBSTITUTED HETEROCYCLYL SULFONES
-
Page/Page column 111; 112, (2015/11/09)
The invention relates to aryl substituted heterocyclyl sulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
Heterocyclic antiviral compounds
-
Page/Page column 12, (2010/02/15)
The present invention relates to a compounds according to formula I, methods for treating diseases mediated by human immunodeficieny virus by administration of a compound according to formula I and pharmaceutical compositions for treating diseases mediated by human immunodeficieny virus containing a compound according to formula I where R1, R2, R3, R4, R5, are as defined herein.
Substituted imidazol-pyridazine derivatives
-
Page 21, (2010/02/05)
The present invention relates to compounds of formula wherein A is an unsubstituted or substituted cyclic group; and R is hydrogen or lower alkyl; or a pharmaceutically acceptable acid addition salt thereof. These compounds are NMDA NR-2B receptor subtype specific blockers and are useful in the treatment of neurodegeneration, depression and pain.
